Literature DB >> 30659781

The first ophthalmic Choosing Wisely recommendations in Finland for glaucoma and wet age-related macular degeneration.

Raimo Tuuminen1,2, Raija Sipilä3, Jorma Komulainen3, Ville Saarela4,5, Kai Kaarniranta6,7, Anja Tuulonen8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30659781     DOI： 10.1111/aos.14031

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  3 in total

1.  Off-label use of bevacizumab for wet age-related macular degeneration in Europe.

Authors:  Tomas Bro; Magdalena Derebecka; Øystein Kalsnes Jørstad; Andrzej Grzybowski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-30       Impact factor: 3.117

2.  Expression of VEGFA-regulating miRNAs and mortality in wet AMD.

Authors:  Janusz Blasiak; Cezary Watala; Raimo Tuuminen; Niko Kivinen; Ali Koskela; Hannele Uusitalo-Järvinen; Anja Tuulonen; Mateusz Winiarczyk; Jerzy Mackiewicz; Szymon Zmorzyński; Agata Filip; Kai Kaarniranta
Journal:  J Cell Mol Med       Date:  2019-10-21       Impact factor: 5.310

3.  Autophagy Genes for Wet Age-Related Macular Degeneration in a Finnish Case-Control Study.

Authors:  Jussi J Paterno; Ali Koskela; Juha M T Hyttinen; Elina Vattulainen; Ewelina Synowiec; Raimo Tuuminen; Cezary Watala; Janusz Blasiak; Kai Kaarniranta
Journal:  Genes (Basel)       Date:  2020-11-06       Impact factor: 4.096
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.